Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas

American Journal of Pathology

Volumn 159, Issue 5, 2001, Pages 1925-1932

  Krams, Matthias ^a   Claviez, Alexander ^a   Heidorn, Klaus ^a   Krupp, Guido ^a   Parwaresch, Reza ^a   Harms, Dieter ^a   Rudolph, Pierre ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; NEUROBLASTOMA; NEWBORN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

EID: 0035153387     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63039-8     Document Type: Article

References (57)

1. Spontaneous regression of neuroblastoma
2. Histologic patterns of neuroblastoma related to prognosis and clinical staging
3. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas
4. Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee
5. Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: A report from the Childrens Cancer Study Group
6. Peripheral neuroblastic tumors: Pathologic classification based on recommendations of international neuroblastoma pathology committee (Modification of Shimada classification)
7. Specific association of human telomerase activity with immortal cells and cancer
8. A survey of telomerase activity in human cancer
9. Mammalian telomere dynamics: Healing, fragmentation shortening and stabilization
10. Telomere reduction in human colorectal carcinoma and with ageing
11. Telomerase, cell immortality, and cancer
12. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes
13. Telomerase activity in normal human epithelial cells
14. Telomeres and telomerase in normal and malignant haematopoietic cells
15. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
16. Telomerase activity: A biomarker of cell proliferation, not malignant transformation
17. Telomerase activity is associated with cell cycle deregulation in human breast cancer
18. Telomerase activity in relation to p53 status and clinicopathological parameters in breast cancer
19. Correlating telomerase activity levels with human neuroblastoma outcomes
20. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma
21. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: A molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues
22. The RNA component of human telomerase
23. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
24. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
25. Telomerase catalytic subunit homologs from fission yeast and human
26. A mammalian telomerase-associated protein
27. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
28. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
29. Reconstitution of human telomerase activity in vitro
30. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues
31. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
32. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
33. The International Neuroblastoma Pathology Classification (the Shimada system)
34. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment
35. Telomerase activity in melanocytic lesions: A potential marker of tumor biology
36. Characteristics of Hodgkin's disease-derived cell lines
37. Prognostic significance of the proliferative activity in neuroblastoma
38. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
39. Look AT: Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma
40. Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay
41. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age
42. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium
43. Multivariate evaluation of prognostic factors in localized neuroblastoma
44. Telomerase is controlled by protein kinase c-alpha in human breast cancer cells
45. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells
46. Mechanism of telomerase induction during T cell activation
47. Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture
48. Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding
49. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues
50. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes
51. Expression profile of the putative catalytic subunit of the telomerase gene
52. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67
53. Induction of telomerase activity in stimulated human lymphocytes precedes expression of topoisomerase II alpha
54. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus
55. The human telomerase catalytic subunit hTERT: Organization of the gene and characterization of the promoter
56. Telomerase activity as a prognostic factor in neuroblastomas